Nystatin pastilles and suspension in the treatment of oral candidosis

被引:13
作者
Millns, B
Martin, MV
机构
[1] Dept. of Clinical Dental Sciences, University of Liverpool
关键词
D O I
10.1038/sj.bdj.4809214
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Clinical audit revealed that the treatment of oral candidosis was more successful with nystatin pastilles than with nystatin suspension. The purpose of this investigation was to determine the reasons for this observation. The concentration of nystatin needed to kill 49 consecutive clinical isolates of Candida albicans was measured. The isolates varied in cidal concentrations from 1.875 to 30 U/ml. The time taken to kill these isolates at their cidal concentrations was found to vary from 120 to 300 min. Volunteer studies showed that antifungal activity in the oral cavity was eliminated rapidly after the use of nystatin suspension. In contrast, the polyene could be detected for at least 5 hours after use of the nystatin pastille. The nystatin pastille can be expected to be more effective at killing Candida albicans than the suspension due to its persistent effects.
引用
收藏
页码:209 / 211
页数:3
相关论文
共 11 条
[1]  
CASTELLANI A, 1963, Mycopathol Mycol Appl, V20, P1, DOI 10.1007/BF02054872
[2]  
HAMILTONMILLER JM, 1974, MICROBIOS, V10, P91
[3]  
HOLBROOK WP, 1979, BR J HOSP MED, V55, P692
[4]  
HOLT RJ, 1981, LAB METHODS ANTIMICR, P249
[5]   FACTORS INFLUENCING SUSCEPTIBILITY OF CANDIDA-ALBICANS TO POLYENOIC ANTIBIOTICS NYSTATIN AND AMPHOTERICIN-B [J].
JOHNSON, B ;
WHITE, RJ ;
WILLIAMSON, GM .
JOURNAL OF GENERAL MICROBIOLOGY, 1978, 104 (FEB) :325-333
[6]   MODE OF ACTION OF CLINICALLY IMPORTANT ANTIFUNGAL DRUGS [J].
KERRIDGE, D .
ADVANCES IN MICROBIAL PHYSIOLOGY, 1986, 27 :1-72
[7]  
MARTIN MV, 1986, BR DENT J, V166, P201
[8]   COLLABORATIVE INVESTIGATION OF VARIABLES IN SUSCEPTIBILITY TESTING OF YEASTS [J].
PFALLER, MA ;
RINALDI, MG ;
GALGIANI, JN ;
BARTLETT, MS ;
BODY, BA ;
ESPINELINGROFF, A ;
FROMTLING, RA ;
HALL, GS ;
HUGHES, CE ;
ODDS, FC ;
SUGAR, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1648-1654
[9]  
*ROYAL PHARM SOC G, 1994, BRIT NAT FORM, P418
[10]   ANTIFUNGAL DRUG SUSCEPTIBILITY TESTING - A CRITICAL-REVIEW [J].
STEVENS, DA .
MYCOPATHOLOGIA, 1984, 87 (03) :135-140